International Journal of Cancer Medicine


International Journal of Cancer Medicine (DOI prefix: 10.46619) (Impact Factor: 3.32) is an International open access, peer-reviewed journal with a broad scope covering all areas of cancer research, especially novel concepts and theories, new methods/techniques, new therapeutic agents, and alternative approaches for early detection and intervention of cancer.

Journal focuses to entrench the field of cancer or oncology by publishing articles focused upon disease management, hinderance/prevent, methods for early diagnosis, and specific classes of therapeutic agents, results of a clinical trial, an emerging interventional technique, supportive care, and rehabilitation/reconstruction. Journal provides platform for rapid publication of high quality results in cancer research while maintaining rigorous single blinded peer-review process.

At this stage, the submission and publication of manuscripts is at discount for all students/emeritus professor. The published articles are made freely available to online readers.

Authors Funded by the NIH: This journal automatically deposits papers to PubMed Central after publication of an issue (NIHMS,

COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC
Get the latest research

Acceptance Rate
Days to process
Days to publish
Total Articles

Recently Published Articles

Research Article | Volume 6, Issue 3 | Open Access
Are the Oncologists Trained for Decision Making on Geriatric Cancer Patients - A Survey of Turkish Oncology Group (TOG)

Sule Karabulut Gul, Huseyin Tepetam, Didem Colpan Oksuz, Omar Alomari, Muhammad Wasif Saif, Serdar Turhal, and Fazilet Oner Dincbas

Research Article | Volume 6, Issue 3 | Open Access
Prognostic Value of Cut-off of Lymph Nodes Number and Ratio in Operated Early-Stage Lung Cancer

Luca Frasca, Valentina Marziali, Filippo Longo, Giovanni Tacchi, Marrelli Martina and Pierfilippo Crucitti

Case Report | Volume 6, Issue 3 | Open Access
A Case Report of Placental Chorioangioma with Adverse Maternal and Perinatal Outcomes

Kawsar Diab, Ghinwa Shehab, Jihad Al Hasan, Hassan Ajami, Marwan Saliba, and Kariman Ghazal

Research Article | Volume 6, Issue 3 | Open Access
Secondary Malignancies after among Patients with Myelodysplastic Syndrome

Jacqueline Nieto Maria, Sheila Firoozan, Sunita Patruni and Muhammed Wasif Saif

Clinical Image | Volume 6, Issue 3 | Open Access
Incidental Mucinous Cystadenoma with Stromal Luteinization Associated with Pregnancy

Harty Ashby, William Kendall, Grayson Jones, Tiffany Thompson, Lina Abdallah, and Fadi Al Akhrass

Clinical Research | Volume 6, Issue 3 | Open Access
Psychological Impact and Sexual Behavior in Patients with Genital and Anal Condylomatosis

M Trigui, H Smaoui, A. Chaabouni, A Samet, L Chtourou, M Fourati, I Mejdoub, W Smaoui, O Kammoun, MA Mseddi, J Mziou, N Rebai, H Turki, N Tahri, and M Hadj slimen

Case Report | Volume 6, Issue 2 | Open Access
Sclerosing PEComa of the Ureter

Irache Abáigar Pedraza, Santiago Moreno Pérez de la Cruz, Azucena Lirio Armas Álvarez and Andrés López de Alda

Research Article | Volume 6, Issue 2 | Open Access
Development and Validation of Prognostic Nomograms for Predicting Postoperative Survival in Patients with Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study

Hui-Ke Wang, Xi Luo, Ya-Lan Yang, Tai-Ying Lu, Yan Yan, and Feng Wang

Clinical Image | Volume 6, Issue 2 | Open Access
Voluminous Bilateral Breast Cancer in the Youngest Woman Seen in the Oncology Department Joseph Ravoahangy Andrianavalona Hospital

Ny Ony Tiana Florence Andrianandrasana, Rabarison Zo, Raeliarisoa Jean Junniot and Florine Rafaramino

Aims & Scope

Main aim of the International Journal of Cancer Medicine is to improve and share knowledge & global health outcomes by publishing Research article, Review, Case reports to convey important practice messages and best research should be published and made widely accessible as quickly as possible in scientific community. Cancer Medicine Journal welcome all kind of articles covering areas of Cancer Biology, Clinical Cancer Research, Cancer Prevention, and other related fields.

The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:

  • Cancer
  • Cancer Diseases
  • Endocrine disorders
  • Breast cancer
  • Blood diseases
  • Cancer statistics
  • Cancer diagnosis
  • Carcinogenesis - etiology, mechanisms
  • Molecular biology
  • Recent developments in tumor therapy
  • General diagnosis
  • Laboratory diagnosis
  • Diagnostic and experimental pathology
  • Oncologic surgery
  • Epidemiology
  • Treatment strategies
  • Evaluations of current therapies
  • Models for integrating complementary and conventional treatment in clinical practice
  • Interventions from alternative and traditional medicine
  • Implementing quality-of-life assessment and counseling in the clinical setting
  • Cancer rehabilitation during and following cancer treatments
  • Potential interactions of cancer chemotherapy drugs with frequently used dietary supplements
  • Implementing integrative cancer care strategies into oncology practice
  • Relevant molecular mechanisms and biology behind integrative approaches
  • Impact of timing of chemotherapy administration on toxicity
  • Response, and outcome by leading oncologists
  • Researchers, and health-care professionals
  • Cancer Medicine and Metastasis